(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 61.10%8.11M | 4.34%18.94M | -52.99%7.31M | -43.93%5.03M | -29.50%2.67M | -14.36%18.15M | 0.81%15.54M | -25.61%8.97M | -42.59%3.79M | -46.83%21.2M |
Operating income | 61.10%8.11M | 4.34%18.94M | -52.99%7.31M | -43.93%5.03M | -29.50%2.67M | -14.36%18.15M | 0.81%15.54M | -25.61%8.97M | -42.59%3.79M | -46.83%21.2M |
Cost of sales | ---4.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating expenses | -4.46M | |||||||||
Gross profit | -27.45%3.65M | 5.03M | ||||||||
Administrative expenses | 8.82%-12.53M | 6.25%-32.27M | 11.14%-21.18M | 9.10%-13.74M | 5.70%-7.12M | -5.97%-34.42M | 0.28%-23.83M | 6.24%-15.12M | 9.65%-7.55M | -114.11%-32.48M |
Impairment and provision | -78.49%91K | 108.18%50K | 718.75%524K | 560.94%423K | --300K | -192.72%-611K | -90.29%64K | -90.29%64K | ---- | 100.90%659K |
-Other impairment is provision | -78.49%91K | 108.18%50K | 718.75%524K | 560.94%423K | --300K | -192.72%-611K | -90.29%64K | -90.29%64K | ---- | 100.92%659K |
Special items of operating profit | -94.53%86K | -4.43%583K | 268.77%2.57M | 142.75%1.57M | 6,673.91%1.51M | 135.24%610K | 139.19%698K | -69.52%648K | -101.45%-23K | 93.40%-1.73M |
Operating profit | -29.60%-8.7M | 21.96%-12.7M | -43.09%-10.78M | -23.57%-6.72M | 30.35%-2.63M | -31.65%-16.27M | 21.62%-7.53M | -65.90%-5.44M | -128.24%-3.78M | 85.29%-12.36M |
Financing cost | -6.77%-6.84M | 8.37%-12.58M | 6.44%-9.54M | 4.26%-6.41M | 4.08%-3.15M | -16.12%-13.72M | -17.88%-10.19M | -16.46%-6.69M | -18.36%-3.29M | 11.24%-11.82M |
Share of profits of associates | ---- | -152.46%-462K | -17,300.00%-522K | ---292K | ---269K | ---183K | ---3K | ---- | ---- | ---- |
Earning before tax | -15.88%-15.55M | 14.72%-25.73M | -17.53%-20.84M | -10.62%-13.42M | 14.33%-6.06M | -24.81%-30.18M | 2.89%-17.73M | -34.41%-12.13M | -59.41%-7.07M | 75.16%-24.18M |
Tax | 171.25%223K | -21.33%59K | 75.33%-318K | 48.35%-313K | -80.29%-247K | 188.46%75K | -32.89%-1.29M | -40.60%-606K | 19.88%-137K | 105.52%26K |
After-tax profit from continuing operations | -11.61%-15.32M | 14.71%-25.67M | -11.24%-21.15M | -7.81%-13.73M | 12.53%-6.3M | -24.64%-30.1M | 1.09%-19.02M | -34.69%-12.74M | -56.47%-7.21M | 75.30%-24.15M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | 134.35%2.28M | 540.15%2.28M | ---516K | ---222K | ---6.64M |
Earning after tax | -11.61%-15.32M | 7.72%-25.67M | -26.39%-21.15M | -3.61%-13.73M | 15.14%-6.3M | 9.64%-27.82M | 15.23%-16.74M | -40.15%-13.25M | -61.29%-7.43M | 68.51%-30.79M |
Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 101.28%335K |
Profit attributable to shareholders | -11.61%-15.32M | 7.72%-25.67M | -26.39%-21.15M | -3.61%-13.73M | 15.14%-6.3M | 10.61%-27.82M | 16.65%-16.74M | -35.35%-13.25M | -61.29%-7.43M | 56.60%-31.12M |
Basic earnings per share | -4.96%-0.0254 | 16.98%-0.044 | -13.46%-0.0371 | 11.36%-0.0242 | 27.45%-0.0111 | 50.47%-0.053 | 62.41%-0.0327 | 61.00%-0.0273 | -410.00%-0.0153 | -33.75%-0.107 |
Diluted earnings per share | -4.96%-0.0254 | 16.98%-0.044 | -13.46%-0.0371 | 11.36%-0.0242 | 27.45%-0.0111 | 50.47%-0.053 | 62.41%-0.0327 | 61.00%-0.0273 | -410.00%-0.0153 | -33.75%-0.107 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data